4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-018501
Chief Scientific Officer sold 27,165 shares at $15.71 ($426,803)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Monahan Joseph Chief Scientific Officer | 2022-03-10 | Sale | −27,165 | $15.71 | $426,803 | 136,386 | D |
| Open-market sales · 27,165 sh · avg $15.71 · $426,803 | |||||||
Loading xslF345X03/doc4.xml…